What is Global Oral Typhoid Vaccine Market?
The Global Oral Typhoid Vaccine Market is a significant segment of the pharmaceutical industry that focuses on the production, distribution, and application of oral typhoid vaccines. Typhoid fever, a life-threatening illness caused by the bacterium Salmonella Typhi, is a global health concern, especially in developing countries where access to clean water and sanitation facilities is limited. The oral typhoid vaccine is a crucial tool in combating this disease, providing immunity by stimulating the body's immune system to produce antibodies that can fight off the bacteria. The market encompasses various stakeholders, including vaccine manufacturers, healthcare providers, and patients, and is influenced by factors such as disease prevalence, vaccine efficacy, and government immunization programs.
Live-attenuated Vaccine, Live Vaccine in the Global Oral Typhoid Vaccine Market:
Live-attenuated Vaccine and Live Vaccine are two types of vaccines available in the Global Oral Typhoid Vaccine Market. Live-attenuated vaccines use a weakened form of the bacteria that causes typhoid. Although it's alive, the bacteria is too weak to cause disease in healthy people. Instead, it stimulates the immune system to produce a response, including the production of antibodies. This type of vaccine is often used in areas where typhoid is endemic. On the other hand, Live Vaccine uses a harmless virus to deliver a piece of the bacteria's DNA into cells in the body. This DNA instructs the cells to produce a protein that is part of the bacteria, triggering an immune response. Both types of vaccines play a crucial role in preventing typhoid, especially in regions where the disease is prevalent.
Adults, Children, Elderly in the Global Oral Typhoid Vaccine Market:
The Global Oral Typhoid Vaccine Market caters to different age groups, including adults, children, and the elderly. For adults, the vaccine is typically recommended for those traveling to areas where typhoid is common. It's also suggested for people who work in microbiology labs that frequently handle Salmonella Typhi bacteria. For children, the vaccine is usually given at the age of two, particularly in high-risk areas. It's also recommended for children traveling to countries where typhoid is prevalent. The elderly, due to their weakened immune systems, are also advised to get vaccinated, especially if they are in a typhoid-endemic area or are traveling to one. The usage of the vaccine across these different age groups underscores its importance in public health.
Global Oral Typhoid Vaccine Market Outlook:
The Global Oral Typhoid Vaccine Market's outlook is promising. In 2022, the market was valued at US$ 35 million. It's projected to grow to US$ 47 million by 2029, which represents a Compound Annual Growth Rate (CAGR) of 4.5% from 2023 to 2029. This growth can be attributed to several factors, including the increasing prevalence of typhoid fever in many parts of the world, the effectiveness of the vaccine in preventing the disease, and the ongoing efforts of governments and international organizations to promote vaccination. The market's growth signifies the increasing recognition of the vaccine's role in combating typhoid fever and improving public health.
| Report Metric | Details |
| Report Name | Oral Typhoid Vaccine Market |
| Accounted market size in 2022 | US$ 35 million |
| Forecasted market size in 2029 | US$ 47 million |
| CAGR | 4.5% |
| Base Year | 2022 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Berna Biotech, Emergent BioSolutions |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
